Zytoprotec at a Glance

Zytoprotec is a clinical stage life sciences company based in Vienna, Austria.

The Company’s lead product, PD-protec®, is a patent-protected solution for peritoneal dialysis. PD-protec® has moved into a randomized, blinded, multicenter Phase II trial at the end of Q2 2014.

Next in Zytoprotec’s pipeline is ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. ICO-protec is in preclinical development.

Since its inception in 2007, the Company has raised approximately EUR 17 million from its founders, from private investors, and from Austrian and European public agencies.